A noninvasive clinicopathologic and gene expression profiling (CP-GEP)–based tool, the Merlin assay, shows promise for ...

Sentinel lymph node (SLN) status alone is not sufficient as node negative patients still experience relapse and melanoma-related death.Validates Merlin CP-GEP's prognostic power: Identifying ...